BABruce J. Aronow

Bruce J. Aronow

*This is an algorithmically generated author record based on publicly available information.

Bruce J. Aronow has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • David P. Witte

    Division of Pathology, Children’s Hospital Research Foundation, Cincinnati, Ohio 45229

    2 shared publications
  • Amy Moseley

    Molecular Genetics, Microbiology and Biochemistry, University of Cincinnati College of Medicine, Cincinnati 45267

    1 shared publication
  • Anil G. Jegga

    Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA

    1 shared publication
  • Arthur Barrie

    Children's Hospital Research Foundation, Cincinnati, Ohio 45242

    1 shared publication
  • Ashima Gupta

    Division of Pediatric Informatics, Children’s Hospital Research Foundation, Cincinnati, Ohio 45229

    1 shared publication
  • Cathy Ley-Ebert

    Division of Molecular and Developmental Biology, Children’s Hospital Research Foundation, Cincinnati, Ohio 45229

    1 shared publication

Latest Publications

  • Neural system-enriched gene expression: relationship to biological pathways and neurological diseases

    by Jianhua Zhang, Amy Moseley, Anil G. Jegga, Ashima Gupta, David P. Witte, Maureen Sartor, Mario Medvedovic, Sarah S. Williams, Cathy Ley-Ebert, Lique M. Coolen, et al.

    To understand the commitment of the genome to nervous system differentiation and function, we sought to compare nervous system gene expression to that of a wide variety of other tissues by gene expression database construction and mining. Gene expression profiles of 10 different adult nervous tissues were compared with that of 72 other tissues. Using ANOVA, we identified 1,361 genes whose expression was higher in the nervous system than other organs and, separately, 600 genes whose expression was at least threefold higher in one or more regions of the nervous system compared with their median expression across all organs. Of the 600 genes, 381 overlapped with the 1,361-gene list. Limited in situ gene expression analysis confirmed that identified genes did represent nervous system-enriched gene expression, and we therefore sought to evaluate the validity and significance of these top-ranked nervous system genes using known gene literature and gene ontology categorization criteria. Diverse functional categories were present in the 381 genes, including genes involved in intracellular signaling, cytoskeleton structure and function, enzymes, RNA metabolism and transcription, membrane proteins, as well as cell differentiation, death, proliferation, and division. We searched existing public sites and identified 110 known genes related to mental retardation, neurological disease, and neurodegeneration. Twenty-one of the 381 genes were within the 110-gene list, compared with a random expectation of 5. This suggests that the 381 genes provide a candidate set for further analyses in neurological and psychiatric disease studies and that as a field, we are as yet, far from a large-scale understanding of the genes that are critical for nervous system structure and function. Together, our data indicate the power of profiling an individual biologic system in a multisystem context to gain insight into the genomic basis of its structure and function.


  • Apolipoprotein J/Clusterin Prevents a Progressive Glomerulopathy of Aging

    by Mark E. Rosenberg, Richard Girton, David Finkel, David Chmielewski, Arthur Barrie, David P. Witte, Guang Zhu, John J. Bissler, Judith A. K. Harmony, Bruce J. Aronow

    Apoliprotein J (apoJ)/clusterin has attracted considerable interest based on its inducibility in multiple injury processes and accumulation at sites of remodeling, regression, and degeneration. We therefore sought to investigate apoJ/clusterin's role in kidney aging, as this may reveal the accumulated effects of diminished protection. Aging mice deficient in apoJ/clusterin developed a progressive glomerulopathy characterized by the deposition of immune complexes in the mesangium. Up to 75% of glomeruli in apoJ/clusterin-deficient mice exhibited moderate to severe mesangial lesions by 21 months of age. Wild-type and hemizygous mice exhibited little or no glomerular pathology. In the apoJ/clusterin-deficient mice, immune complexes of immunoglobulin G (IgG), IgM, IgA, and in some cases C1q, C3, and C9 were detectable as early as 4 weeks of age. Electron microscopy revealed the accumulation of electron-dense material in the mesangial matrix and age-dependent formation of intramesangial tubulo-fibrillary structures. Even the most extensively damaged glomeruli showed no evidence of inflammation or necrosis. In young apoJ/clusterin-deficient animals, the development of immune complex lesions was accelerated by unilateral nephrectomy-induced hyperfiltration. Injected immune complexes localized to the mesangium of apoJ/clusterin-deficient but not wild-type mice. These results establish a protective role of apoJ/clusterin against chronic glomerular kidney disease and support the hypothesis that apoJ/clusterin modifies immune complex metabolism and disposal.